MDR Escherichia coli carrying CTX-M-24 (IncF[F-:A1:B32]) and KPC-2 (IncX3/IncU) plasmids isolated from community-acquired urinary trainfection in Brazil

Braz J Infect Dis. 2022 Nov-Dec;26(6):102706. doi: 10.1016/j.bjid.2022.102706. Epub 2022 Oct 11.

Abstract

Acquired antibiotic resistance in bacteria has become an important worldwide challenge. Currently, several bacteria, including Escherichia coli, have multidrug resistance profiles. Genes such as bla CTX-M-24 and bla KPC-2 (carbapenemase) are widespread. This research letter reports about a genomic surveillance study where multidrug-resistant E. coli containing CTX-M-24(IncF [F-:A1:B32]) and KPC-2(IncX3/IncU) plasmids were obtained from community- acquired urinary tract infection in Brazil.

Keywords: CTX-M-24; Escherichia coli; KPC-2; Urinary tract infection.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Brazil
  • Escherichia coli Infections* / microbiology
  • Escherichia coli* / genetics
  • Humans
  • Plasmids / genetics
  • beta-Lactamases / genetics

Substances

  • beta-Lactamases
  • Anti-Bacterial Agents